Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

Eur Radiol. 2021 Jun;31(6):4409. doi: 10.1007/s00330-020-07592-0.
No abstract available

Publication types

  • Published Erratum